WARPTECHNEWS · LAB

Home AI Business Tech Archive

WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

Home
Archivio
Editor's Brief
Cerca
Il tuo account
Newsletter tech/AI

Informazioni legali

Privacy Policy
Termini di servizio
Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Storia in 4 fonti

Eli Lilly invests in startup Abridge for clinical trial recruitment

Eli Lilly has invested in Abridge as the health tech startup expands into clinical trial recruitment and broadens its reach into the life sciences.

Raccontata da

fiercehealthcare.com

Confronto fonti

4 prospettive sulla stessa storia

AI · summaries

endpoints.newsStai leggendo9 h fa

Eli Lilly invests in startup Abridge for clinical trial recruitment

Eli Lilly has invested in Abridge as the health tech startup expands into clinical trial recruitment and broadens its reach into the life sciences.

Timeline cronologica

giovedì 11 giugno 2026·fiercehealthcare.com
Abridge picks up strategic investment from Eli Lilly, expands payer, research workflows
Since launching eight years ago with an ambient medical transcription tool, Abridge has set is sights more broadly on building out a full-scale AI clinical assistant. | Abridge…
giovedì 11 giugno 2026·statnews.com
Abridge inks deals with Nvidia and Lilly
Abridge announced new deals with Eli Lilly and Nvidia as it aims to gain an edge in a competitive market.

fiercehealthcare.com

1 g fa

Abridge picks up strategic investment from Eli Lilly, expands payer, research workflows

Since launching eight years ago with an ambient medical transcription tool, Abridge has set is sights more broadly on building out a full-scale AI clinical assistant. | Abridge secured a strategic investment from Eli…

Leggi questa versione → originale

statnews.com1 g fa

Abridge inks deals with Nvidia and Lilly

Abridge secures strategic investment from Eli Lilly and Nvidia partnership to develop purpose-built foundation model for clinical conversations. Specialized domain models replace generic AI as market requirement for competitive enterprise healthcare adoption.

Leggi questa versione → originale

fortune.com1 g fa

Abridge wants to be the operating system for medicine—and NVIDIA and Eli Lilly are helping build it | Fortune

Abridge ($5.3B Series E, NVIDIA/Eli Lilly) scaled ambient AI from transcription into clinical decisions, billing, and trial screening across 300+ systems. Platform creates moat connecting providers-payers-pharma via PHI, but risks mount as AI notes become permanent records.

Leggi questa versione → originale

giovedì 11 giugno 2026·

fortune.com

Abridge wants to be the operating system for medicine—and NVIDIA and Eli Lilly are helping build it | Fortune

The $5.3 billion ambient AI startup is expanding from clinical notes into billing, drug trials, and real-time insurance claims.

venerdì 12 giugno 2026·

endpoints.news

Eli Lilly invests in startup Abridge for clinical trial recruitment

Eli Lilly has invested in Abridge as the health tech startup expands into clinical trial recruitment and broadens its reach into the life sciences.